Search research articles
Contact Us
Filters
Showing results (151-160 of 159) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 159 results.
Journal of the American College of Cardiology
|
May 1, 1994
Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators
C R Benedict, D E Johnstone, D H Weiner, et al.
Journal of the American College of Cardiology
|
October 1, 1993
Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. The SOLVD Investigators
C R Benedict, D H Weiner, D E Johnstone, et al.
Circulation
|
March 18, 1997
Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis
E O Weinberg, M A Lee, M Weigner, et al.
Journal of Agricultural and Food Chemistry
|
September 19, 2002
Use of a rat model to evaluate tall fescue seed infected with introduced strains of Neotyphodium coenophialum
C A Roberts, D E Spiers, A L Karr, et al.
Circulation Research
|
January 1, 1992
ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries
S K Yao, J C Ober, J McNatt, et al.
Cancer
|
March 15, 1997
Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Dolasetron Dose-Response Study Group
E B Rubenstein, R J Gralla, J D Hainsworth, et al.
The Cancer Journal From Scientific American
|
January 1, 1997
Oral dolasetron mesylate in patients receiving moderately emetogenic platinum-containing chemotherapy. Oral Dolasetron Dose Response Study Group
T H Grote, L F Pineda, R A Figlin, et al.
Metabolism: Clinical and Experimental
|
September 17, 2013
The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans
Beth A Connolly, Daniel P O'Connell, Stefania Lamon-Fava, et al.
American Heart Journal
|
July 1, 1997
Acute and long-term effects of the angiotensin-converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction
R D Patten, M W Kronenberg, C R Benedict, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 159) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 159 results.
Journal of the American College of Cardiology
|
May 1, 1994
Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators
C R Benedict, D E Johnstone, D H Weiner, et al.
Journal of the American College of Cardiology
|
October 1, 1993
Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. The SOLVD Investigators
C R Benedict, D H Weiner, D E Johnstone, et al.
Circulation
|
March 18, 1997
Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis
E O Weinberg, M A Lee, M Weigner, et al.
Journal of Agricultural and Food Chemistry
|
September 19, 2002
Use of a rat model to evaluate tall fescue seed infected with introduced strains of Neotyphodium coenophialum
C A Roberts, D E Spiers, A L Karr, et al.
Circulation Research
|
January 1, 1992
ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries
S K Yao, J C Ober, J McNatt, et al.
Cancer
|
March 15, 1997
Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Dolasetron Dose-Response Study Group
E B Rubenstein, R J Gralla, J D Hainsworth, et al.
The Cancer Journal From Scientific American
|
January 1, 1997
Oral dolasetron mesylate in patients receiving moderately emetogenic platinum-containing chemotherapy. Oral Dolasetron Dose Response Study Group
T H Grote, L F Pineda, R A Figlin, et al.
Metabolism: Clinical and Experimental
|
September 17, 2013
The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans
Beth A Connolly, Daniel P O'Connell, Stefania Lamon-Fava, et al.
American Heart Journal
|
July 1, 1997
Acute and long-term effects of the angiotensin-converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction
R D Patten, M W Kronenberg, C R Benedict, et al.
Page
of 16